Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 138 of 1,261
  1. US 11896617

    Polynucleotides encoding rituximab-resistant chimeric antigen receptors

    Allogene Therapeutics, Inc. Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  2. US 11896643

    Fibroblast binding agents and use thereof

    Orionis Biosciences, Inc Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  3. US 11896417

    Time-varying kinetic modeling of high temporal-resolution dynamic pet data for multiparametric imaging

    The Regents of the University of California Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  4. US 11897874

    Compounds and methods for modulating Interleukin-2-inducible T-cell kinase

    Corvus Pharmaceuticals, Inc. Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  5. US 11897945

    Methods of treating allergy using anti-Bet v 1 antibodies

    REGENERON PHARMACEUTICALS, INC. Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  6. US 11898165

    Engineered host cells and methods of use thereof

    MiNK Therapeutics, Inc. Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  7. US 11898166

    In vitro generation of thymic organoid from human pluripotent stem cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  8. US 11898207

    Methods of isolating neoantigen-specific T cell receptor sequences

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  9. US 11896580

    Composition for improving milk quality and preparation method and application thereof

    China Agricultural University Β· Granted Feb 13, 2024 Β· Expires Feb 8, 2044

    granted
  10. AU 2022206771

    Drug conjugates comprising antibodies against Claudin 18.2

    ASTELLAS PHARMA INC [JP] Β· Granted Feb 8, 2024 Β· Expires Feb 3, 2044

    granted
  11. US 11891426

    CD19 variants

    Regents of the University of Minnesota Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  12. US 11890281

    SHP2 phosphatase inhibitors and methods of making and using the same

    Relay Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  13. US 11890285

    Combination therapies

    Mirati Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  14. US 11890289

    Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

    Corcept Therapeutics Incorporated Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  15. US 11890307

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  16. US 11890320

    CLEC11A is a bone growth agent

    The Board of Regents of the University of Texas System Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  17. US 11890330

    Endolysins active against Bacillus bacteria, pharmaceutical compositions, and methods relating thereto

    United States of America as represented by the Secretary of the Air Force Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  18. US 11890353

    Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies

    Northwestern University Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  19. US 11890354

    Activatable antibodies that bind epidermal growth factor receptor and methods thereof

    CytomX Therapeutics, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  20. US 11890415

    Airway management systems for pulmonary disorder treatment

    Covidien LP Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  21. US 11890344

    One-step processing of hydrogels for mechanically robust and chemically desired features

    The Board of Regents of the University of Texas System Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  22. US 11890359

    Zirconia composition, partially sintered material and sintered material and methods for production thereof, and laminate

    KURARAY NORITAKE DENTAL INC. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  23. US 11891393

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted
  24. US 11891399

    Inhibitors of cancer invasion, attachment, and/or metastasis

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Feb 6, 2024 Β· Expires Feb 1, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.